Brazil halted a late-stage trial of a Chinese vaccine on Monday that had been considered a global front-runner in the race to develop a protective shot for the coronavirus after a “serious adverse” reaction in a participant.

The decision provoked a political firestorm on Tuesday after President Jair Bolsonaro, who has been critical of China and spoken dismissively of its vaccine, CoronaVac, called the suspension a political victory.